George M. Gill
- Genetics top 5%
- Oncology top 10%
- Molecular Biology
- Infectious Diseases top 10%
- Biotechnology top 5%
- Co-authors
- Matt CoffeyRalph C. BensonKimberly KicielinskiE. Antonio ChioccaJohn S. YuJames M. MarkertK.L. MettingerGordon Loewen
- Topics
- Virus-based gene therapy research (14 papers)Cancer Research and Treatments (9 papers)Viral gastroenteritis research and epidemiology (8 papers)
- Cited by
- GeneticsBiotechnologyOncology
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
George M. Gill
22 papers receiving 718 citations
Peers
Comparison fields: 5 of 64
- Genetics 428
- Oncology 345
- Molecular Biology 308
- Infectious Diseases 161
- Biotechnology 125
Countries citing papers authored by George M. Gill
This map shows the geographic impact of George M. Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George M. Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George M. Gill more than expected).
Fields of papers citing papers by George M. Gill
This network shows the impact of papers produced by George M. Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George M. Gill. The network helps show where George M. Gill may publish in the future.
Co-authorship network of co-authors of George M. Gill
This figure shows the co-authorship network connecting the top 25 collaborators of George M. Gill. A scholar is included among the top collaborators of George M. Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George M. Gill. George M. Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 9 | |
| 3 | 16 | |
| 4 | 42 | |
| 5 | 118 | |
| 6 | 9 | |
| 7 | 6 | |
| 8 | 3 | |
| 9 | 5 | |
| 10 | 98 | |
| 11 | 2 | |
| 12 | 116 | |
| 13 | 8 | |
| 14 | 4 | |
| 15 | A Phase I study of LGD1069 in adults with advanced cancer. | 88 |
| 16 | Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer. | 23 |
| 17 | Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid. | 55 |
| 18 | Estramustine phosphate: plasma concentrations of its metabolites following oral administration to man, rat and dog. | 22 |
| 19 | 29 | |
| 20 | 7 |
About George M. Gill
George M. Gill is a scholar working on Biotechnology, Genetics and Infectious Diseases, having authored 22 papers that have together received 747 indexed citations. Recurring topics across this work include Virus-based gene therapy research (14 papers), Cancer Research and Treatments (9 papers) and Viral gastroenteritis research and epidemiology (8 papers). The work is most often cited by research in Genetics (428 citations), Biotechnology (125 citations) and Oncology (345 citations). George M. Gill has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Matt Coffey, Ralph C. Benson, Kimberly Kicielinski, E. Antonio Chiocca, John S. Yu, James M. Markert, K.L. Mettinger, Gordon Loewen, Matthew Coffey and E H Ulm. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.